CAS No. |
315-22-0 |
中文名称 |
(3R,4R,5R,8a1R,13aR)-4,5-二羟基-3,4,5-三甲基-4,5,8,8a1,10,12,13,13a-八氢-2H-[1,6]二氧杂环十一烷基[2,3,4-gh]吡咯嗪-2,6(3H)-二酮 |
英文名称 |
(3R,4R,5R,8a1R,13aR)-4,5-dihydroxy-3,4,5-trimethyl-4,5,8,8a1,10,12,13,13a-octahydro-2H-[1,6]dioxacycloundecino[2,3,4-gh]pyrrolizine-2,6(3H)-dione |
别名 |
(13-alpha,14-alpha)-14,19-dihydro-12,13-dihydroxy-20-norcrotalanan-11,15-dio;(13-alpha,14-alpha)-14,19-Dihydro-12,13-dihydroxy-20-norcrotalanan-11,15-dione;(2,3,4-gh)pyrrolizine-2,6(3h)-dione,(4,5,8,10,12,13,13a,13b-octahydro-4,5-dihy;(2,3,4-gh)pyrrolizine-2,6(3H)-dione,(4,5,8,10,12,13,13a,13b-octahydro-4,5-dihydroxy-3,4,5-trimethyl-2H-(1,6)dioxacycloundecino-;12-beta,13-beta-dihydroxy-12-alpha,13-alpha,14-alpha-trimethylcrotal-1-enine;12beta,13beta-Dihydroxy-12alpha,13alpha,14alpha-trimethylcrotal-1-enine;14,19-dihydro-12,13-dihydroxy(13-alpha,14-alpha)-20-norcrotalanan-11,15-dione;14,19-Dihydro-12,13-dihydroxy(13alpha,14alpha)-20-norcrotalanan-11,15-dione |
标准英文名 |
(3R,4R,5R,8a1R,13aR)-4,5-dihydroxy-3,4,5-trimethyl-4,5,8,8a1,10,12,13,13a-octahydro-2H-[1,6]dioxacycloundecino[2,3,4-gh]pyrrolizine-2,6(3H)-dione |
分子式 |
C16H23NO6 |
分子量 |
325.15
|
精确分子量 |
325.15
|
SMILES |
O=C1O[C@@]2([H])[C@]3([H])N(CC=C3COC([C@](O)([C@](O)([C@H]1C)C)C)=O)CC2 |
标准SMILES |
C[C@H]1C(=O)O[C@@H]2CCN3CC=C(COC(=O)[C@](C)(O)[C@]1(C)O)[C@@H]32 |
用途 |
Used topically for the treatment of skin cancers, particularly squamous cell carcinoma and basal cell carcinoma; administered by local injection for cervical cancer and penile cancer; exhibits inhibitory effects against various experimental tumors; used in content determination, identification, and pharmacological studies; employed as a pyrrolizidine alkaloid to induce pulmonary disease in rats. |
InChIKey |
QVCMHGGNRFRMAD-XFGHUUIASA-N |